Flamel Technologies (FLML): Great Buying Opportunity Before Earnings Inflection
The biotech sell-off presents a great buying opportunity in Flamel Technologies shares. The stock has declined more than 30% over three recent trading days despite significant improvement in fundamentals that should drive much higher earnings potential this year and next. The shares appreciated nearly 50% in March as initiation of coverage by a number of sell-side firms began to hint at the very significant value in the shares. The shares had held up well over the past month through much of the biotechnology crash but succumbed to huge selling pressure in recent days, which looks to me to be related to forced liquidations at some biotechnology-focused hedge funds. We expect the...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|